Andere Sprachen Aion Therapeutic Inc.

Aktien

A2QCBY

CA00905T1021

AION

Verzögert Canadian Securities Exchange Andere Börsenplätze 17:47:19 16.04.2024			% 5 Tage	% 1. Jan.
0,015 ^CAD	-25,00 %		0,00 %	-25,00 %

02.04.	Aion Therapeutic Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024	CI
02.01.	Aion Therapeutic Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Oktober 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority	12.04.
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	02.04.
Aion Therapeutic Engages Independent Trading Group for Market Making Services	04.03.
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	02.01.
Canadian Investment Regulatory Organization Trade Resumption - AION	18.12.
Aion Therapeutic Announces Closing of Toppen Health Inc. Acquisition	16.12.
Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc.	15.12.
Aion Therapeutic Announces Definitive Agreement to Acquire Toppen Health Inc.	23.10.23
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health Inc. for $4.9 million.	23.10.23
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health for $4.9 million.	23.10.23
Canadian Investment Regulatory Organization Trading Halt - AION	19.10.23
Aion Therapeutic Announces Closing of Second Tranche of Non-Brokered Private Placement Offering of Units	06.10.23
Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding	05.10.23
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	28.09.23
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	28.08.23
Aion Therapeutic Announces Closing of Non-Brokered Private Placement Offering of Units	14.08.23
Aion Therapeutic Inc. announced that it has received CAD 0.4275 million in funding	14.08.23
Aion Therapeutic Announces Director Resignation	06.07.23
Aion Therapeutic Announces Resignation of Rosy Mondin as Director	06.07.23
Canadian Investment Regulatory Organization Trade Resumption - AION	04.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aion Therapeutic Inc.

Aktien

A2QCBY

CA00905T1021

AION

Andere Sprachen

Filter